Selective Serotonin Reuptake Inhibitors and Symptoms of Depression in Patients on Chronic Hemodialysis: A Systematic Review
Selektive Serotonin-Wiederaufnahmehemmer und Depressionssymptome bei Patient:innen an chronischer Hämodialyse: systematische Übersicht
Journal of Clinical Medicine · 05.06.2024 · 13 (11) · 3334
DOI: 10.3390/jcm13113334 ↗Auf einen Blick
Sieben Studien mit 433 Patient:innen untersuchten SSRIs bei chronischer Hämodialyse. Die Daten waren heterogen; eine Metaanalyse war nicht möglich.
Fragestellung
Wie wirksam sind SSRIs bei Patient:innen an chronischer Hämodialyse im Vergleich zu Placebo oder psychologischen Interventionen zur Reduktion von Depressionssymptomen?
Methode
Systematische Übersicht randomisierter kontrollierter Studien; Suche im Dezember 2023 in Ovid MEDLINE, Ovid EMBASE, Cochrane Library und PubMed.
Ergebnisse
7 Studien mit 433 Patient:innen. Heterogene Daten verhinderten eine informative Metaanalyse. Sertralin war in 2 von 3 Studien besser als Placebo; eine Studie zeigte keinen signifikanten Unterschied.
Einschränkungen
Heterogene Daten; geringe Zahl an Studien und Patient:innen.
Schlussfolgerung der Autor:innen
SSRIs können Depressionssymptome bei Patient:innen an chronischer Hämodialyse verringern. Die in den eingeschlossenen Studien verwendete Dosierung scheint bei den meisten Patient:innen sicher zu sein.
Kernaussagen
- 7 Studien mit insgesamt 433 Patient:innen
- Heterogene Daten verhinderten eine Metaanalyse
- SSRIs könnten Depressionssymptome reduzieren
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 05.06.2024. Verfasst von Maurizio Bossola und 5 weiteren Autor:innen. Beteiligte Einrichtung: Servizio Emodialisi, Dipartimento di Scienze Mediche e Chirurgiche, Università Cattolica del Sacro Cuore, 00168 Rome, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Objective
The use of selective serotonin reuptake inhibitors (SSRIs) is common among hemodialysis patients who receive treatment for depression. However, studies on the efficacy of SSRIs in patients on chronic hemodialysis are few and have led to conflicting results. The present systematic review aims to evaluate, in randomized, controlled studies (RCSs), the efficacy of SSRI administration in reducing symptoms of depression in patients on chronic hemodialysis when compared with placebo or psychological interventions.
Method
Research was run on December 2023 in the following databases: Ovid MEDLINE (1985 to present); Ovid EMBASE (1985 to present); Cochrane Library (Wiley); and PubMed (1985 to present). The primary outcome was the frequency and severity of the symptoms of depression assessed through the Beck Depression Inventory (BDI) or the Hamilton Depression Rating Scale (HAMD). The secondary outcome was the prevalence of adverse events.
Results
Seven studies totaling 433 patients were included. The number of patients in each individual study ranged from 13 to 120. The length of studies ranged from 8 weeks to 6 months. Heterogeneous data precluded informative meta-analysis. Three studies compared sertraline with a placebo. Of these, two demonstrated that sertraline was better than the placebo in reducing the symptoms of depression while one showed no statistically significant differences between sertraline and the placebo. One study, comparing fluoxetine with a placebo showed that the symptoms of depression did not differ significantly at 8 weeks. In another study, escitalopram administration led to a significantly greater reduction in the Hamilton Depression Rating Scale score compared to a placebo, as well as in the Hamilton Anxiety Rating Scale score. In one study, citalopram and psychological interventions were both effective in reducing the symptoms of depression and anxiety and, in another study, sertraline was modestly more effective than CBT at 12 weeks in reducing the symptoms of depression.
Conclusions
SSRIs may be effective in reducing the symptoms of depression in patients on chronic hemodialysis. SSRI administration, at the dosage used in the studies included in the present systematic review, seems safe in most hemodialysis patients. However, the paucity of studies and the limited number of patients included in the trials may suggest that further randomized, controlled studies are needed to determine if SSRIs may be used routinely in daily clinical practice in such a population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Servizio Emodialisi, Dipartimento di Scienze Mediche e Chirurgiche, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
- Policlinico Universitario Fondazione Agostino Gemelli IRCCS, 00168 Rome, Italy.
- Dipartimento Scienze dell'Invecchiamento, Neurologiche, Ortopediche e Della Testa-Collo, 00168 Rome, Italy.
- Divisione Chirurgia d'Urgenza, Dipartimento di Scienze Mediche e Chirurgiche, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
- Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
ORCID-Profile: Maurizio Bossola, Ilaria Mariani
Zitieren
APA
Bossola, M., Mariani, I., Antocicco, M., Pepe, G., Petrosino, A., & Di Stasio, E. (2024). Selective Serotonin Reuptake Inhibitors and Symptoms of Depression in Patients on Chronic Hemodialysis: A Systematic Review. Journal of Clinical Medicine, 13(11), 3334. https://doi.org/10.3390/jcm13113334
Vancouver
Bossola M, Mariani I, Antocicco M, Pepe G, Petrosino A, Di Stasio E. Selective Serotonin Reuptake Inhibitors and Symptoms of Depression in Patients on Chronic Hemodialysis: A Systematic Review. Journal of Clinical Medicine. 2024;13(11):3334. doi:10.3390/jcm13113334
BibTeX
@article{Bossola2024,
author = {Bossola, Maurizio and Mariani, Ilaria and Antocicco, Manuela and Pepe, Gilda and Petrosino, Anna and Di Stasio, Enrico},
title = {Selective Serotonin Reuptake Inhibitors and Symptoms of Depression in Patients on Chronic Hemodialysis: A Systematic Review},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {11},
pages = {3334},
doi = {10.3390/jcm13113334}
}
EUVIMED